CIK 0001736243 · <br>Emerging growth company
Acurx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ACXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-533-1469
- Business address
- 259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
- Former names
- Acurx Pharmaceuticals, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-06 | Scodari Joseph C Director | Purchase | +24,631 | $1.02 | $25K | 27,708 |
| 2025-01-06 | Sailer Carl Director | Purchase | +24,631 | $1.02 | $25K | 137,183 |
| 2025-01-06 | LUCI DAVID P President and CEO | Purchase | +49,261 | $1.02 | $50K | 1,097,458 |
| 2025-01-06 | Donohue James J. Director | Purchase | +9,852 | $1.02 | $10K | 22,352 |
| 2025-01-06 | DELUCCIA ROBERT J Director | Purchase | +49,261 | $1.02 | $50K | 1,010,196 |
| 2025-01-06 | DEAN JACK H Director | Purchase | +9,852 | $1.02 | $10K | 21,776 |
| 2022-07-27 | Sailer Carl Director | Purchase | +19,737 | $3.80 | $75K | 92,815 |
| 2022-07-27 | DELUCCIA ROBERT J Director | Purchase | +19,737 | $3.80 | $75K | 1,051,198 |
| 2022-07-27 | LUCI DAVID P President and CEO | Purchase | +19,737 | $3.80 | $75K | 1,028,460 |
| 2021-11-23 | Sailer Carl Director | Purchase | +5,161 | $4.84 | $25K | 73,078 |
| 2021-11-19 | DELUCCIA ROBERT J Director | Purchase | +5,034 | $4.90 | $25K | 1,031,461 |
| 2021-11-19 | LUCI DAVID P President and CEO | Purchase | +5,200 | $4.80 | $25K | 1,008,723 |
| 2021-06-29 | Sailer Carl Director | Purchase | +12,500 | $6.00 | $75K | 67,917 |
Page 1 of 1 · 13 trades